We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 10

FDA simplifying physician application process for compassionate use of unapproved drugs
  • King & Spalding LLP
  • USA
  • February 9 2015

On February 4, 2015, FDA released draft guidance around its "Expanded Access" program, also known as "compassionate use." The guidance proposes a


OIG publishes Fiscal Year 2012 work plan
  • King & Spalding LLP
  • USA
  • October 11 2011

Last week, the U.S. Department of Health and Human Services’ Office of Inspector General (OIG) published its work plan for the 2012 fiscal year in which it described its primary objectives for the year.


CMS FAQs on Advanced Diagnostic Imaging Accreditation
  • King & Spalding LLP
  • USA
  • June 6 2011

On May 24, 2011, the Centers for Medicare and Medicaid Services (CMS) posted 10 new FAQs related to Advanced Diagnostic Imaging Accreditation.


Elizabeth N. Swayne
  • King & Spalding LLP


J. Austin Broussard
  • King & Spalding LLP

Mike Paulhus
  • King & Spalding LLP

Preeya M. Noronha
  • King & Spalding LLP

Krista Mills Barnes
  • King & Spalding LLP

Patrick Morrisey
  • King & Spalding LLP